Literature DB >> 19160603

Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa.

M E Craanen1, P Blok, W Dekker, J Ferwerda, G N Tytgat.   

Abstract

A prospective gastroscopic-bioptic study of 533 patients was performed to assess the prevalence and distribution of intestinal metaplasia (IM) and its subtypes in the antral mucosa of patients with various upper intestinal disorders and to assess whether the presence of certain IM subtypes might be of help in selecting patients for careful endoscopic-bioptic surveillance in the screening for gastric carcinoma. IM was found in 135 patients (25.3%). Its prevalence increased with age (P < 0.001) and was strongly associated with intestinal-type carcinoma as compared to diffuse-type carcinoma (P < 0.001), gastritis (P < 0.001), and gastric ulcer (P < 0.05). Type I IM was predominant (98.5%), whereas types II and III IM, respectively, were found in 77.8% and 15.6% of the patients with IM. No difference in the prevalence of type I and II IM was found among the various gastric disease states. Type III IM was strongly associated with intestinal-type carcinoma as compared to either benign lesions (P < 0.01) or diffuse-type carcinoma. These results suggest that type III IM may play a special role in the histogenesis of intestinal-type carcinoma and suggest that the finding of this IM subtype in gastric biopsies may possibly be of help in identifying patients at greater risk of developing carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 19160603     DOI: 10.1007/bf01296393

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY.

Authors:  S S SPICER
Journal:  J Histochem Cytochem       Date:  1965-03       Impact factor: 2.479

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Screening for gastric cancer in the West.

Authors: 
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

4.  Precursors of gastric and esophageal cancer.

Authors:  P Correa
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

5.  The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma.

Authors:  J R Jass; M I Filipe
Journal:  Histochem J       Date:  1981-11

6.  Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample.

Authors:  P Sipponen; M Kekki; M Siurala
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

7.  Histochemical characterization of different types of intestinal metaplasia in gastric mucosa.

Authors:  D I Segura; C Montero
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

8.  Time trend in the prevalence of intestinal metaplasia in Japan.

Authors:  T Imai; H Murayama
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

9.  Adenocarcinoma of the stomach: are we making any progress?

Authors:  C M McBride; A W Boddie
Journal:  South Med J       Date:  1987-03       Impact factor: 0.954

10.  Significance of mass survey for gastric cancer from the standpoint of surgery.

Authors:  N Kaibara; H Kawaguchi; H Nishidoi; O Kimura; T Okamoto; S Koga; S Fukumoto
Journal:  Am J Surg       Date:  1981-11       Impact factor: 2.565

View more
  7 in total

Review 1.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Authors:  Carlos A González; José M Sanz-Anquela; Javier P Gisbert; Pelayo Correa
Journal:  Int J Cancer       Date:  2013-02-05       Impact factor: 7.396

2.  [Carcinoma of the gastric stump. Diagnosis, surgical procedure and prognosis].

Authors:  P Kujath; C Eckmann; R Broll; A Woltmann; G Hohlbach
Journal:  Langenbecks Arch Chir       Date:  1995

3.  Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma.

Authors:  Z K Mirza; K K Das; J Slate; R N Mapitigama; P S Amenta; L H Griffel; L Ramsundar; J Watari; K Yokota; H Tanabe; T Sato; Y Kohgo; K M Das
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Image quantitation of intestinal metaplasia in entire gastrectomy specimens from Swedish and Japanese patients.

Authors:  C A Rubio; M Matthies; M Itabashi; T Hirota
Journal:  Jpn J Cancer Res       Date:  1996-07

5.  AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Authors:  Osama Altayar; Perica Davitkov; Shailja C Shah; Andrew J Gawron; Douglas R Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

6.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

Authors:  N Broutet; M Plebani; C Sakarovitch; P Sipponen; F Mégraud
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

7.  Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations.

Authors:  Perica Davitkov; Osama Altayar; Shailja C Shah; Andrew J Gawron; Reem A Mustafa; Shahnaz Sultan; Douglas R Morgan
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.